What is the GHS hazard classification for Di(2-ethylhexyl) phthalate?
Di(2-ethylhexyl) phthalate (CAS 117-81-7) is classified under EU CLP Annex VI as Repr. 1B with signal word Danger. Hazard statements: H360FD. Source: EU CLP Annex VI (ECHA).
Also known as: 1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester, DEHP, Bis-(2-ethylhexyl)-phthalate, di(alpha-Ethylhexyl) phthalate, 2-Ethylhexyl phthalate (+15 more)
CAS 117-81-7
Di(2-ethylhexyl) phthalate (CAS 117-81-7) is a chemical substance with GHS signal word Danger; key hazard signal: H360FD. Key regulatory status: SVHC Candidate List, California Proposition 65, REACH registered, 60 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from ECHA CLP, EPA ToxValDB, EPA CPDat, AICIS, IARC, ECHA REACH, ECHA SVHC, CA Prop 65, ILO ICSC, OSHA, EPA TRI.
View cosmetic safety profile for Diethylhexyl Phthalate (DEHP) →
Di(2-ethylhexyl) phthalate is prohibited in EU cosmetics but has active industrial GHS classifications (H360FD).
CAS, identifiers, formula, and alternate names for the matched substance record.
Carcinogenic hazard classification from IARC monograph evaluations.
| Group | Meaning | Evaluated | Volume |
|---|---|---|---|
| Group 2B | Possibly carcinogenic | 2011 | Sup 7, 77, 101 |
Candidate List status and reason under the ECHA REACH SVHC program.
| Substance | Reason | Included |
|---|---|---|
| Bis (2-ethylhexyl)phthalate (DEHP) | Toxic for reproduction (Article 57c); Endocrine disrupting properties (Article 57(f) - environment); Endocrine disrupting properties (Article 57(f) - human health) | 28-Oct-2008 |
California OEHHA listing status and toxicity category.
| Chemical | Toxicity Type | Cancer | Developmental | Listed |
|---|---|---|---|---|
| - | cancer | Yes | No | - |
| - | developmental, male | No | Yes | - |
| - | developmental, male | No | Yes | - |
| - | developmental, male | No | Yes | - |
| - | developmental, male | No | Yes | - |
| - | developmental, male | No | Yes | - |
| - | developmental, male | No | Yes | - |
| - | developmental, male | No | Yes | - |
EU harmonized hazard classification, hazard statements, pictograms, and signal word.
| Hazard Class | H-Statements | Pictograms | Signal |
|---|---|---|---|
| Repr. 1B | H360FD | GHS08 | Danger |
International Chemical Safety Card hazard and exposure summary.
| Field | Value |
|---|---|
| Short-term Effects | The substance is irritating to the eyes and respiratory tract. |
| Long-term Effects | The substance may have effects on the testes. Animal tests show that this substance possibly causes toxicity to human reproduction or development. |
| Routes of Exposure | The substance can be absorbed into the body by inhalation, through the skin and by ingestion. |
Occupational exposure limits from OSHA, NIOSH, and ACGIH rows.
| Agency | Metric | Value | ppm | mg/m3 | Skin |
|---|---|---|---|---|---|
| OSHA | TWA | 5 mg/m³ | - | 5 | N |
| NIOSH | TWA | 5 mg/m³ | - | 5 | N |
| NIOSH | STEL | 10 mg/m³ | - | 10 | N |
| ACGIH | TWA | 5 mg/m³ [1996] | - | 5 | N |
| CAL/OSHA | TWA | 5 mg/m³ | - | 5 | N |
| NIOSH | IDLH | 5000 mg/m³ | - | 5000 | - |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| banned; Europe; Personal care | European Commission | CosIng |
| detected; Europe; Vehicle - car interior | Danish Environmental Protection Agency | Danish EPA |
| detected; emissions; Europe; Other indirect contact consumer goods; water | Danish Environmental Protection Agency | Danish EPA |
| detected; Toys and children's products | American Public Health Association | Published Articles |
| Arts and crafts/Office supplies - children's art and toys - modeling clay; detected | Springer | Published Articles |
| air; detected; emissions; Europe; Vehicle - car interior | Danish Environmental Protection Agency | Danish EPA |
| fracking; water | NY Department of Conservation | CPCat |
| air; detected; emissions; Europe; Vehicle - car interior | Danish Environmental Protection Agency | Danish EPA |
| air; detected; emissions; Europe; Vehicle - car interior | Danish Environmental Protection Agency | Danish EPA |
| air; detected; emissions; Europe; Vehicle - car interior | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Vehicle - car interior | Danish Environmental Protection Agency | Danish EPA |
| drinking_water; Europe; manufacturing; plastic_additive | Belgaqua | CPCat |
| Indirect additives food contact (10/2018) | FDA | United States Food and Drug Administration (FDA) |
| detected; Other direct contact consumer goods; Toys and children's products | Reproductive Toxicology | Published Articles |
| IFRA Transparency | IFRA | IFRA |
| consumer_product | P&G | Proctor & Gamble |
| OEHHA Proposition 65 (3/2019) | STATE OF CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY | OEHHA Proposition 65 List |
| OEHHA Proposition 65 (1/2023) | California Office of Environmental Health Hazard Assessment | OEHHA Proposition 65 List |
| detected; Europe; Other direct contact consumer goods; Toys and children's products | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Toys and children's products | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Other direct contact consumer goods | Danish Environmental Protection Agency | Danish EPA |
| detected; Europe; Toys and children's products | Danish Environmental Protection Agency | Danish EPA |
| Europe; plastic_additive | European Chemicals Agency | European Chemicals Agency (ECHA) |
| children | Vermont Department of Health | State of Vermont |
| detected; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| children | Oregon Health Authority | State of Oregon |
| children; WA Children's Safe Product Act (4/2020) | State of Washington Department of Ecology | State of Washington |
| detected; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| detected; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| detected; Personal care - child specific; Personal care - specialized bath products - bubble bath; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| children; detected; Personal care - make-up and related; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| children; detected; Personal care - body hygiene - body wash; Personal care - fragrance | State of Washington Department of Ecology | State of Washington |
| detected; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| detected; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| children; detected; Packaging (non-food contact) | State of Washington Department of Ecology | State of Washington |
| active_ingredient; Pesticides | State of California | State of California |
| consumer_product | P&G | Proctor & Gamble |
| Europe; Food contact items | Danish Environmental Protection Agency | Danish EPA |
| drinking_water; Europe; soil | Danish Environmental Protection Agency | Danish EPA |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 6170 | nM | AC50/EC50/IC50 | - | - | NTP_ICE_endocrine |
| >100000 | nM | AC50/EC50/IC50 | - | - | NTP_ICE_endocrine |
| 190000 | nM | AC50/EC50/IC50 | - | - | NTP_ICE_endocrine |
| 428000 | nM | AC50/EC50/IC50 | - | - | NTP_ICE_endocrine |
| 450000 | nM | AC50/EC50/IC50 | - | - | NTP_ICE_endocrine |
| =3.8 | mg/kg bw/day | BMDL | oral | Rat | ToxValDB_MN_MDH_HHBW |
| ABoral=410 (adult); 58 (infant boys, age 29 days to 24 months); 20 (neonatal infant boys, age 0 to 28 days); Adultb: 4200 (intravenous); Infant boys, age 29 days to 24 monthsb: 600 (intravenous); Neonatal infant boys, age 0 to 28 daysb: 210 (intravenous); Adultb: oral=410; Infant boys, age 29 days to 24 monthsb: oral=58; Neonatal infant boys, age 0 to 28 daysb: oral=20 | ug/day | California Proposition 65 MADL | - | - | California Proposition 65 |
| ABoral=410 (adult); 58 (infant boys, age 29 days to 24 months); 20 (neonatal infant boys, age 0 to 28 days); Adultb: 4200 (intravenous); Infant boys, age 29 days to 24 monthsb: 600 (intravenous); Neonatal infant boys, age 0 to 28 daysb: 210 (intravenous); Adultb: oral=410; Infant boys, age 29 days to 24 monthsb: oral=58; Neonatal infant boys, age 0 to 28 daysb: oral=20 | ug/day | California Proposition 65 MADL | - | - | California Proposition 65 |
| ABoral=410 (adult); 58 (infant boys, age 29 days to 24 months); 20 (neonatal infant boys, age 0 to 28 days); Adultb: 4200 (intravenous); Infant boys, age 29 days to 24 monthsb: 600 (intravenous); Neonatal infant boys, age 0 to 28 daysb: 210 (intravenous); Adultb: oral=410; Infant boys, age 29 days to 24 monthsb: oral=58; Neonatal infant boys, age 0 to 28 daysb: oral=20 | ug/day | California Proposition 65 MADL | - | - | California Proposition 65 |
| SQE310 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| SQE310 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| SQE310 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| SQEcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABdevelopmental, male | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABdevelopmental, male | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABdevelopmental, male | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| 2.646 | uL/min/10^6 cells | Clint | - | Human | NTP_ICE_adme_parameters |
| 10.73 | uL/min/10^6 cells | Clint | - | Rat | NTP_ICE_adme_parameters |
| =1.6 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| C42K0PH13C | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| C42K0PH13C | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| C42K0PH13C | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| C42K0PH13C | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| - | fraction | Fu | - | Human | NTP_ICE_adme_parameters |
| 0.2152 | fraction | Fu | - | Rat | NTP_ICE_adme_parameters |
| 2B | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 2B | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 2B | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 2 | unitless | IARC group | - | - | NTP_ICE_cancer |
| >20000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| >25000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =30000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =0.05 | mg/kg bw/day | LEL | oral | rodent | ToxValDB_EPA_TSCA_8e |
| =32.5 | uL/L-day | LEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =48 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =100 | ppm | LEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =100 | mg/kg bw/day | LEL | oral | rodent | ToxValDB_EPA_TSCA_8e |
| =288 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =325 | uL/L-day | LEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =357 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =357 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =500 | ppm | LEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =500 | mg/kg bw/day | LEL | oral | Rabbit | ToxValDB_EPA_TSCA_8e |
| =591 | mg/kg bw/day | LEL | oral | Mouse | ToxValDB_EPA_TSCA_8e |
| =600 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =600 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =666 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =750 | mg/kg bw/day | LEL | oral | Rabbit | ToxValDB_EPA_TSCA_8e |
Showing 50 of 100 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Bis(2-ethylhexyl) phthalate | 204-211-0 | ECHA overview → |
TRI hazard and reporting flags for the matched chemical.
| Chemical | Category | Flags |
|---|---|---|
| Di(2-ethylhexyl) phthalate | - | - |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
ADI: 50 mg/kg bw
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Di(2-ethylhexyl) phthalate (CAS 117-81-7) is classified under EU CLP Annex VI as Repr. 1B with signal word Danger. Hazard statements: H360FD. Source: EU CLP Annex VI (ECHA).
Di(2-ethylhexyl) phthalate has 100 NOAEL studies in the database. The lowest reported value is 0.03 % diet via oral in Mouse. Source: ToxValDB_EPA_TSCA_8e.
Di(2-ethylhexyl) phthalate appears on 35 regulatory/inventory lists including banned; Europe; Personal care, detected; Europe; Vehicle - car interior, detected; emissions; Europe; Other indirect contact consumer goods; water, and 32 more. Source: EPA CPDat.
Di(2-ethylhexyl) phthalate is classified by IARC as Group 2B — possibly carcinogenic to humans (evaluated 2011). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
Yes, Di(2-ethylhexyl) phthalate is listed under California Proposition 65 for cancer. Source: California OEHHA Proposition 65.
Yes, Di(2-ethylhexyl) phthalate is listed on the ECHA REACH Candidate List as a Substance of Very High Concern. Reason: Toxic for reproduction (Article 57c); Endocrine disrupting properties (Article 57(f) - environment); Endocrine disrupting properties (Article 57(f) - human health). Source: ECHA SVHC Candidate List.
Occupational exposure limits for Di(2-ethylhexyl) phthalate are set by OSHA, NIOSH, ACGIH. 6 limit values from official agencies are documented in the database. Source: OSHA, NIOSH, ACGIH.
Yes, Di(2-ethylhexyl) phthalate is also indexed as a cosmetic ingredient under the name Diethylhexyl Phthalate (DEHP). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from ECHA CLP Annex VI, EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, IARC Monographs, ECHA REACH, ECHA SVHC Candidate List, California Proposition 65, ILO/WHO ICSC, OSHA/NIOSH/ACGIH, EPA Toxics Release Inventory, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Di(2-ethylhexyl) phthalate is prohibited in EU cosmetics but has active industrial GHS classifications (H360FD).
Di(2-ethylhexyl) phthalate also appears in cosmetics, pharmaceutical, food safety, cannabis databases.